Lincoln Pharmaceuticals Secures CRISIL A/Stable Rating

🏥 CRISIL has reaffirmed

’ credit ratings, assigning CRISIL A/Stable for long-term facilities and CRISIL A1 for short-term facilities. The reaffirmation reflects the company’s strong financial profile, healthy cash flows, and stable business fundamentals.